Humankind Investments LLC Amgen Inc Transaction History

Humankind Investments LLC

$371 Million
Q1 2024

A detailed history of Humankind Investments LLC transactions in Amgen Inc stock. As of the latest transaction made, Humankind Investments LLC holds 4,064 shares of AMGN stock, worth $1.26 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

4,064

Previous 4,027 0.92%

Holding current value

$1.26 Million

Previous $1.16 Million 0.35%

% of portfolio

0.31%

Previous 0.35%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$268.87 - $324.56 $9,948 - $12,008	37 Added 0.92%	4,064 $1.16 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $19,944 - $22,499	-78 Reduced 1.9%	4,027 $1.16 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $162,019 - $201,151	-741 Reduced 15.29%	4,105 $1.1 Million
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $9,213 - $10,894	-43 Reduced 0.88%	4,846 $1.08 Million
Q1 2023 Apr 25, 2023	BUY	$225.79 - $275.2 $181,986 - $221,811	806 Added 19.74%	4,889 $1.18 Million

Q4 2022 Jan 26, 2023	SELL	$229.03 - $291.01 $128,943 - $163,838	-563 Reduced 12.12%	4,083 $0
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $162,509 - $183,280	724 Added 18.46%	4,646 $1.05 Million
Q2 2022 Aug 05, 2022	SELL	$230.71 - $256.74 $203,947 - $226,958	-884 Reduced 18.39%	3,922 $954,000
Q1 2022 May 09, 2022	SELL	$219.27 - $242.57 $40,784 - $45,118	-186 Reduced 3.73%	4,806 $1.16 Million
Q4 2021 Mar 21, 2022	BUY	$198.88 - $227.6 $174,815 - $200,060	879 Added 21.37%	4,992 $1.12 Million
Q3 2021 Mar 21, 2022	BUY	$212.27 - $248.7 $249,841 - $292,719	1,177 Added 40.09%	4,113 $875,000
Q2 2021 Mar 21, 2022	BUY	$233.58 - $259.14 $252,967 - $280,648	1,083 Added 58.45%	2,936 $716,000
Q1 2021 Mar 21, 2022	BUY	$221.91 - $258.6 $411,199 - $479,185	1,853 New	1,853 $461,000

Others Institutions Holding AMGN

# of Institutions

2,932

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Humankind Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Humankind Investments LLC with notifications on news.

Account

Humankind Investments LLC Amgen Inc Transaction History